Engineering the future of biology with revolutionary genome synthesis and expanded genetic code technology.
The Financial Times published a profile of Constructive Bio, covering the Cambridge-based company's work in synthetic genomics and its mission to engineer organisms with rewritten genetic codes for applications in biomanufacturing and therapeutics.